Market Overview The global gastrointestinal drugs market is experiencing significant innovation through microbiome-targeted therapeutics that are addressing GI disease through manipulation of gut bacterial communities rather than direct treatment of disease pathophysiology. The global gastrointestinal drugs market is projected to exceed USD 80 billion through 2030, fueled by microbiome research...

" According to the latest report published by Data Bridge Market Research, the Intestine Cancer Therapeutics Market The global Intestine Cancer Therapeutics market size was valued at USD 15.97 billion in 2025and is expected to reach USD 29.77 billion by 2033, at a CAGR of 8.10% during the forecast periodThe market growth is largely fueled by the growing adoption and technological...

The estimated glomerular filtration rate (eGFR) is the primary metric used to monitor kidney function and guide treatment decisions in chronic kidney disease (CKD). Glomerular Filtration Rate (GFR) represents the rate at which blood is filtered through the glomeruli, and its decline is a hallmark of CKD progression. Nephrology therapeutics are the medications designed to slow this...

The field of endocrinology therapeutics is dedicated to treating disorders of the endocrine system, and one of its key areas of focus is the management of adult growth hormone deficiency. This condition, while less visible than its pediatric counterpart, can significantly impact the quality of life and long-term health of adults. The development and application of human...

" According to the latest report published by Data Bridge Market Research, the Subcutaneous Nucleic Acid Therapeutics Market The global subcutaneous nucleic acid therapeutics market size was valued at USD 2.88 billion in 2024 and is expected to reach USD 5.02 billion by 2032, at a CAGR of 7.20% during the forecast periodThe market expansion is primarily driven by advancements in...

Anxiety disorders are often characterized by a state of hyperarousal in the central nervous system. Anxiety disorder therapeutics that are classified as CNS depressant medications work by reducing this hyperarousal, calming the brain and nervous system. This category includes benzodiazepine drugs and other sedative-hypnotics. While effective for short-term symptom...

According to the latest report published by Data Bridge Market Research, the Lujo Hemorrhagic Fever (LUHF) Treatment Market  CAGR Value The Lujo Hemorrhagic Fever (LUHF) Treatment Market was valued at USD 40.50 million in 2025 and is projected to reach USD 68.55 million by 2033, growing at a CAGR of 6.80% from 2026 to 2033. An influential Lujo Hemorrhagic Fever (LUHF) Treatment...